Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Suzuken Co., Ltd.
  6. Summary
    9987   JP3398000004

SUZUKEN CO., LTD.

(9987)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Japan Exchange
01/13/2022 01/14/2022 01/17/2022 01/18/2022 01/19/2022 Date
3375(c) 3330(c) 3360(c) 3315(c) 3220(c) Last
128 400 159 000 67 700 89 400 212 500 Volume
-1.46% -1.33% +0.90% -1.34% -2.87% Change
More quotes
Estimated financial data (e)
Sales 2022 2 133 B 18 659 M 18 659 M
Net income 2022 12 063 M 105 M 105 M
Net Debt 2022 - - -
P/E ratio 2022 23,7x
Yield 2022 2,24%
Sales 2023 2 182 B 19 081 M 19 081 M
Net income 2023 14 801 M 129 M 129 M
Net Debt 2023 - - -
P/E ratio 2023 19,0x
Yield 2023 2,24%
Capitalization 283 B 2 479 M 2 477 M
Capi. / Sales 2022 0,13x
Capi. / Sales 2023 0,13x
Nbr of Employees 15 041
Free-Float -
More Financials
Company
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy... 
Sector
Drug Retailers
Calendar
02/09Earnings Release
More about the company
Ratings of Suzuken Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about SUZUKEN CO., LTD.
2021Tranche Update on Suzuken Co., Ltd.'s Equity Buyback Plan announced on May 27, 2021.
CI
2021Suzuken Co., Ltd. agreed to acquire a 49% stake in EP-PharmaLine Co., Ltd. from EPS Hol..
CI
2021Suzuken Co., Ltd.'s Equity Buyback announced on May 27, 2021, has expired with 1,292,00..
CI
2021Doctors Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.
CI
2021SmartShopping, Inc. announced that it has received funding from Suzuken Co., Ltd., M3, ..
CI
2021Suzuken Revises Earnings Guidance for the Fiscal Year Ending March 31, 2022
CI
2021Suzuken Co., Ltd. Provides Dividend Guidance for the Interim of 2022 and Fiscal Year 20..
CI
2021Tranche Update on Suzuken Co., Ltd.'s Equity Buyback Plan announced on May 27, 2021.
CI
2021SUZUKEN CO., LTD. : Ex-dividend day for interim dividend
FA
2021SUZUKEN CO., LTD.(TSE : 9987) dropped from S&P Japan Mid Cap 100
CI
2021Y&G Limited completed the acquisition of additional 65.7% stake in EPS Holdings, Inc. f..
CI
2021Tranche Update on Suzuken Co., Ltd.'s Equity Buyback Plan announced on May 27, 2021.
CI
2021Suzuken Co., Ltd. announces an Equity Buyback for 1,500,000 shares, representing 1.68% ..
CI
2021Y&G Limited made an offer to acquire remaining 78% stake in EPS Holdings, Inc. from Suz..
CI
2021Suzuken Co., Ltd. authorizes a Buyback Plan.
CI
More news
News in other languages on SUZUKEN CO., LTD.
2021Suzuken Co., Ltd. fournit des indications sur les dividendes pour le semestre et l'exer..
2021Suzuken révise ses prévisions de bénéfices pour l'année fiscale se terminant le 31 mars..
2018Suzuken Co., Ltd. annonce les résultats des bénéfices consolidés pour les neuf mois clo..
2017Suzuken Co., Ltd. annonce les résultats des bénéfices consolidés pour le semestre clos ..
2017Suzuken Co., Ltd. annonce les résultats du bénéfice consolidé pour le premier trimestre..
More news
Chart SUZUKEN CO., LTD.
Duration : Period :
Suzuken Co., Ltd. Technical Analysis Chart | 9987 | JP3398000004 | MarketScreener
Technical analysis trends SUZUKEN CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 3 220,00 JPY
Average target price 3 824,00 JPY
Spread / Average Target 18,8%
EPS Revisions
Managers and Directors
Hiromi Miyata Senior Managing Executive Officer
Toyoake Ota Executive Officer & Manager-Information Systems
Asako Tomita Executive Officer & Manager-Compliance
Masanobu Nohara Manager-Business Administration
Keisuke Ueda Independent Outside Director
Sector and Competitors